Osanetant
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Introduction: The neurokinin 3 (NK3) receptor is a GPCR that has been shown to modulate monoaminergic systems within regions of…
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the…
OBJECTIVE
The present study was designed to examine the efficacy and tolerability of the non-peptide neurokinin-3 (NK3) receptor…
Osanetant is a neurokinin (NK3) receptor antagonist under development by Sanofi-Synthélabo (formerly Sanofi) as a potential…
Aerosolized substance P (0.1 M, for 30 min) induced airway hyperresponsiveness in guinea-pigs 24 h after they were pre-treated…